Most recently, the inhibition of Kdm6 family members with GSK-J4 was shown to abate nephropathy progression in diabetic db/db mice, suggesting that Kdm6a is also involved in the progression of metabolic diseases [17]. This evidence concerns the gene KDM6A and metabolic disease.